AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Simulations Plus Sets Date for Third Quarter Fiscal Year 2021 Earnings Release and Conference Call

June 28, 2021 GMT

LANCASTER, Calif.--(BUSINESS WIRE)--Jun 28, 2021--

Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report its financial results for the third quarter of fiscal year 2021, the period ended May 31, 2021, after the close of the financial markets on Monday, July 12, 2021.

The Company will host a conference call on July 12, 2021, at 4:15 p.m. Eastern Time. All interested parties are invited to join the call by registering here or by calling 1-201-389-0879. Please join five to 10 minutes before the scheduled start time. The call will be simulcast live on the Internet, and the webcast will be available on the Investors page of the Simulations Plus website under Conference Calls & Presentations. A replay of the webcast will be available on the website approximately one hour following the call.

ADVERTISEMENT

About Simulations Plus, Inc.

ADVERTISEMENT

Serving clients worldwide for 25 years, Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With our subsidiaries, Cognigen, DILIsym Services, and Lixoft, we offer solutions which bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, consumer goods companies and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on Twitter | Read our Environmental, Social, and Governance (ESG) Report.

View source version on businesswire.com:https://www.businesswire.com/news/home/20210628005763/en/

CONTACT: Simulations Plus Investor Relations

Ms. Renee Bouche

(661) 723-7723

renee@simulations-plus.comHayden IR

Mr. Brian S. Siegel, IRC®, M.B.A.

(346) 396-8696

slp@haydenir.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: CONSULTING BIOTECHNOLOGY TECHNOLOGY MANUFACTURING PROFESSIONAL SERVICES HEALTH PHARMACEUTICAL RESEARCH SOFTWARE SCIENCE CHEMICALS/PLASTICS

SOURCE: Simulations Plus, Inc.

Copyright Business Wire 2021.

PUB: 06/28/2021 04:15 PM/DISC: 06/28/2021 04:16 PM

http://www.businesswire.com/news/home/20210628005763/en